Publication | Closed Access

Inhibition of nuclear factor-κB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma

MedicineCombined TherapyProteasome Inhibitor BortezomibCancer Cell BiologyTarget GenesHead And Neck CancerCell BiologyCancer TreatmentNeck OncologyRadiation OncologyOncologyCancer TherapeuticsCancer ResearchMolecular OncologyHealth Sciences